| Stage | UFCS | % of rev | HLX | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $384M | 100.00% | $304M | 100.00% | UFCS ×1.26 |
| Gross profit | $383M | 99.71% | $56M | 18.49% | UFCS +81.2pp |
| Operating income | $46M | 11.86% | $27M | 8.79% | UFCS +3.1pp |
| Pre-tax income | $42M | 10.92% | $22M | 7.37% | UFCS +3.5pp |
| Net income | $33M | 8.69% | $23M | 7.47% | UFCS +1.2pp |
| Stage | UFCS | HLX | Gap · A − B |
|---|---|---|---|
| Revenue | $384M100.00% | $304M100.00% | UFCS ×1.26 |
| Gross profit | 99.71%$383M | 18.49%$56M | UFCS +81.2pp |
| Operating income | 11.86%$46M | 8.79%$27M | UFCS +3.1pp |
| Pre-tax income | 10.92%$42M | 7.37%$22M | UFCS +3.5pp |
| Net income |
| 8.69%$33M |
| 7.47%$23M |
| UFCS +1.2pp |
No shared counterparties.